Trials / Completed
CompletedNCT05915871
Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin
An Open-label, Fixed-sequence Study to Evaluate the Drug-drug Interactions Between Tegoprazan Tablets and Bismuth Potassium Citrate Capsules, Amoxicillin Capsules, and Clarithromycin Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic interaction between tegoprazan and combination of Amoxicillin, Clarithromycin and bismuth in healthy adult volunteers.
Detailed description
To evaluate the pharmacokinetic interaction between tegoprazan and combination of Amoxicillin, Clarithromycin and bismuth in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegoprazan | Tablet for oral administration |
| DRUG | Bismuth | Capsule for oral administration |
| DRUG | Amoxicilli | Capsule for oral administration |
| DRUG | Clarithromycin | Tablet for oral administration |
Timeline
- Start date
- 2023-03-23
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2023-06-23
- Last updated
- 2023-06-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05915871. Inclusion in this directory is not an endorsement.